A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
NCT 06560645 Brief Summary This is a Phase 1 study to determine…
Read more arrow_forwardNCT 06560645 Brief Summary This is a Phase 1 study to determine…
Read more arrow_forwardNCT 06351904 Brief Summary This is an open label, multi-center study…
Read more arrow_forwardNCT 05734105 Brief Summary This is a Phase 3, 2-arm, randomized, open-label,…
Read more arrow_forwardNCT 03157128 Brief Summary This is an open-label, first-in-human study designed to…
Read more arrow_forwardNCT 04819100 Brief Summary The reason for this study is to see…
Read more arrow_forwardNCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…
Read more arrow_forwardNCT 06456463 Brief Summary This study will be divided into 2 parts…
Read more arrow_forwardNCT 04844073 Brief Summary The main aim of this study is to…
Read more arrow_forwardNCT 05253651 Brief Summary This study is being done to find…
Read more arrow_forwardNCT 05152147 Brief Summary This study is being done to find out…
Read more arrow_forward